Cymat Technologies Ltd. CYM

TVX: CYM | ISIN: CA23257A2083   14/05/2024
0,170 CAD (0,00%)
(0,00%)   14/05/2024

3 april 2024 · Cymat Announces First Commercial Order For Non-Lethal Bullets And Provides Alusion™ Orderbook Update · Persbericht

24 januari 2024 · Cymat Announces Major Alusion™ Order For Neom Project · Persbericht

13 oktober 2023 · Cymat Announces Completion Of $1.2 M Private Placement Financing · Persbericht

25 september 2023 · Cymat Announces Private Placement Financing · Persbericht

12 september 2023 · Cymat Announces Successful Automotive Prototype Test Results - Moves Towards Serial Production Pricing · Persbericht

17 juli 2023 · Cymat To Provide Corporate Update Webinar · Persbericht

29 juni 2023 · Cymat Provides Corporate Update On Automotive, Military And Architectural Initiatives And Progress · Persbericht

20 juni 2023 · Cymat Announces Progression To Prototypes And Physical Testing On Automotive Component · Persbericht

21 april 2023 · Cymat Announces Approval Of Warrant Repricing And Warrant Exercise Incentive Program · Persbericht

18 april 2023 · Cymat Updates Warrant Repricing And Warrant Exercise Incentive Program · Persbericht

28 maart 2023 · Cymat Updates Warrant Repricing And Warrant Exercise Incentive Program · Persbericht

7 maart 2023 · Cymat Reprices Warrants And Announces Warrant Exercise Incentive Program · Persbericht

3 januari 2023 · Cymat Reports Second Quarter Results For Fiscal 2023 · Persbericht

13 december 2022 · Cymat Announces Second Auto Component Development Agreement With Its Global Car Manufacturing Customer · Persbericht

4 oktober 2022 · Cymat Reports First Quarter Results For Fiscal 2023 · Persbericht

7 september 2022 · Cymat Announces First Significant Military Serial Production Order · Persbericht

Mijn selecties